Caitlyn Miller
CEO TwoStep Therapeutics
Seminars
Wednesday 22nd July 2026
Preclinical Evaluation & Optimization of a Multi-Specific Targeting Peptide for Radioligand Therapy
12:00 pm
- Scientific rationale for TwoStep Therapeutics’ multi-specific targeting agent (PIP) and how it enables broad applicability across solid tumors
- Comparing the data from a single vs multitargeted approach to highlight the rationale of multi-specific targeting
- Optimization of the PIP-Radio Conjugate for RLT: approach and learnings to improve biodistribution and tumor retention
